Trademarkia Logo

Canada

C$
Trademark Search in Canada
ODYSSEUS

View On IC.GC.CA

ODYSSEUS
FORMALIZED

on 23 Apr 2025

Last Applicant/ Owned by

Trogenix Ltd

Institute of Regeneration & Repair,North Building,5 Little FranceEdinburgh EH16 4UU

GB

Serial Number

2394317 filed on 31st Jan 2025

ODYSSEUS

Trademark usage description

pharmaceutical, medical or veterinary preparations and substances; rna therapeutics; pharmaceutical preparations for use in targeted pharmaceutical th Read More

Classification Information

Class [005]
Pharmaceutical, medical or veterinary preparations and substances; RNA therapeutics; pharmaceutical preparations for use in targeted pharmaceutical therapies; pharmaceutical preparations and products for the treatment of neoplastic diseases; pharmaceutical preparations and products for the treatment of carcinomas and leukaemias; pharmaceutical preparations and products for the treatment of central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumours; enhancers or super-enhancers for medical or clinical use; promoters for medical use; synthetic super enhancers in gene expression cassettes for medical or clinical use; DNA sequences and RNA sequences for medical purposes; transgenes for medical purposes; pharmaceutical preparations for use in regenerative medicines for treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repair; gene therapy pharmaceuticals; pharmaceutical preparations being vectors; biotechnological preparations for medical use; biological compounds for use in the targeted pharmaceutical therapies; proteins with diagnostic and therapeutic uses; chemical and enzyme preparations for medical or veterinary purposes; reagents and substances for use in testing for medical and veterinary purposes; drug delivery agents that facilitate the delivery of pharmaceutical preparations; clinical medical reagents; diagnostic and testing preparations for clinical, medical and medical laboratory use; pharmaceuticals in the field of modulating therapeutics; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of cancer; biological preparations for use in cell cultures for medical purposes; diagnostic biomarker reagents for medical purposes; cells for medical or clinical use; immune cells; target antigens for medical use; vaccine preparations; therapeutic vaccines.

Classification kind code

12

Class [009]
Downloadable computer software programs; downloadable software, namely, lab information management systems; computer software platforms; downloadable software for remote diagnostics; machine learning software; machine learning software for use in genetic sequencing; algorithms, being computer software; bioinformatics software; imaging apparatus and instruments for use in the study of proteins and peptides in drug development; data processing software; downloadable computer applications in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assays; software for predicting protein expression; software in the fields of genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assays; downloadable computer software for scientific analysis of genetic sequences; software algorithms in the fields of biotechnology and modulating therapeutics; software as a medical device; artificial intelligence software in the field of healthcare.

Classification kind code

12

Class [042]
Design, development and maintenance of software in the fields of genetic sequencing, genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering, antibody engineering, microbiology, pharmaceuticals, medicine, diagnostic preparations, immunopharmaceuticals, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assays; design, development and maintenance of software algorithms in the fields of biotechnology and modulating therapeutics; design, development and maintenance of software in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assays; design, development and maintenance of machine learning software for use in bioinformatics, genetic sequencing, predicting protein expression, cell suppression and analysis of cell behaviours; gene regulation control services; gene regulatory network analysis; analysis, management and review of technical data; development and testing of computing methods, algorithms and software; design, development and maintenance of machine learning software; research in the field of artificial intelligence software; design and development of lab information management systems; design and development of software testing methods; providing non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; software as a service [SaaS] platforms and tools for collecting and interpreting clinical data; development and testing of computing methods, algorithms and software; platform as a service services; computer aided analysis services in the field of pharmaceuticals; database development and maintenance services; design and development of computer platforms; research and development services in the fields of pharmacogenetics, targeted pharmaceutical therapies and drug delivery platforms; research and development services in the field of regenerative medicines for the treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repair; research and development services in the fields of pharmaceuticals, immunopharmaceuticals, neoplastic diseases, modulating therapeutics, enhancers, super-enhancers, promoters, synthetic super enhancers in gene expression, DNA sequences, RNA sequences, fluorescent reporters, genetic cassettes, transgenes, gene therapy, drug delivery agents, vectors, diagnostic biomarker reagents, cell cultures, cell engineering, immunology and vaccines; research and development services in the fields of synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering and antibody engineering; research and development services for the treatment of cancers, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumours; research and development services for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological, biochemical, biomedical, bacteriological and pharmacological research, analysis, engineering and development services; biological laboratory services; cell engineering services, namely cell suppression, cell activation, and cell programming and reprogramming; culturing of cells for scientific or medical research purposes; contract research services relating to enhancers, and super-enhancers and promoters; drug development services; development of gene-based medicines; providing information about medical research in the fields of biopharmaceuticals, immunology, cell engineering and immunoassays; scientific services relating to the isolation and cultivation of human tissues and cells; laboratory services namely, research, analysis, characterising, development and production of therapeutics for the treatment of neoplastic diseases, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumours; genetic engineering services; genetic sequencing and genotyping services; RNA sequencing services; analysis services regarding the safety and efficacy of new pharmaceuticals; diagnostic services in the field of immunology; polymerase chain reaction [PCR] services; preparation of reports in the field of biotechnology; testing of human tissues and stem cells for scientific or medical research purposes; use of biomarkers to investigate human immune response for medical purposes; design, research, analysis and engineering services relating to genetic cassettes; design and engineering services relating to genomic safe harbours, recombination sites, minimal promoters, insulators, splicing control elements, gene terminators, UTRs, capsids, fusion linkers, translational control elements and transcriptional units; RNA sequence optimisation services; evaluation services relating to RNA quality; translational control services in the field of gene expression; design of therapeutic payloads; consultancy, information and advisory services relating to all of the aforesaid services.

Classification kind code

12

Mark Details

Serial Number

2394317

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 257
on 24th Apr 2025		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 23rd Apr 2025		Created
Submitted for opposition 31
on 23rd Apr 2025		Formalized
Submitted for opposition 30
on 31st Jan 2025		Filed
Submitted for opposition 228
on 31st Jan 2025		International Registration